Showing results (361-370 of 635) with videos related to

Sort By:
Pageof 64
Molecular Oncology|June 5, 2015
Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinomaPilar Bayo, Adriana Jou, Albrecht Stenzinger, et al.
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.
Pancreas|April 1, 2014
KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinomaBruno V Sinn, Jana K Striefler, Marc A Rudl, et al.
Cold Spring Harbor Molecular Case Studies|January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case reportMarkus Ball, Petros Christopoulos, Martina Kirchner, et al.
BMC Cancer|May 2, 2021
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samplesKatharina Kriegsmann, Christiane Zgorzelski, Thomas Muley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body 18F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
Cancer Medicine|August 16, 2014
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatmentAlbrecht Stenzinger, Nicole Pfarr, Volker Endris, et al.
The European Respiratory Journal|August 31, 2013
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotypeArne Warth, Roland Penzel, Heike Lindenmaier, et al.
Virchows Archiv : an International Journal of Pathology|March 17, 2018
Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasmsStephan Bartels, Akinyele Adisa, Timothy Aladelusi, et al.
World Journal of Gastroenterology|March 22, 2017
hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinomaSumadi Lukman Anwar, Till Krech, Britta Hasemeier, et al.
Pageof 64